United Capital Financial Advisers, LLC Gilead Sciences, Inc. Transaction History

United Capital Financial Advisers, LLC

  • $11.7 Billion
  • Q4 2024

A detailed history of United Capital Financial Advisers, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, United Capital Financial Advisers, LLC holds 203,261 shares of GILD stock, worth $21.9 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
203,261
Previous 246,364 17.5%
Holding current value
$21.9 Million
Previous $20.7 Million 9.08%
% of portfolio
0.16%
Previous 0.1%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
SELL
$83.95 - $97.9 $3.62 Million - $4.22 Million
-43,103 Reduced 17.5%
203,261 $18.8 Million
Q3 2024

Nov 12, 2024
SELL
$66.59 - $83.99 $519,535 - $655,289
-7,802 Reduced 3.07%
246,364 $20.7 Million
Q2 2024

Aug 14, 2024
SELL
$63.15 - $72.88 $689,661 - $795,922
-10,921 Reduced 4.12%
254,166 $17.4 Million
Q1 2024

May 15, 2024
SELL
$71.58 - $87.29 $2.74 Million - $3.34 Million
-38,317 Reduced 12.63%
265,087 $19.4 Million
Q4 2023

Feb 14, 2024
SELL
$73.27 - $83.09 $22.2 Million - $25.2 Million
-303,600 Reduced 50.02%
303,404 $24.6 Million
Q3 2023

Nov 14, 2023
SELL
$73.94 - $80.67 $3.3 Million - $3.6 Million
-44,680 Reduced 6.86%
607,004 $45.5 Million
Q2 2023

Aug 14, 2023
SELL
$76.01 - $86.7 $2.19 Million - $2.5 Million
-28,872 Reduced 4.24%
651,684 $50.2 Million
Q1 2023

Aug 14, 2023
BUY
$77.31 - $88.08 $2.23 Million - $2.54 Million
28,805 Added 4.42%
680,489 $56.5 Million
Q1 2023

May 15, 2023
SELL
$77.31 - $88.08 $1.03 Million - $1.17 Million
-13,298 Reduced 1.92%
680,556 $56.5 Million
Q4 2022

Feb 14, 2023
SELL
$62.32 - $89.47 $1.23 Million - $1.77 Million
-19,762 Reduced 2.77%
693,854 $59.6 Million
Q3 2022

Nov 14, 2022
BUY
$59.54 - $68.01 $379,686 - $433,699
6,377 Added 0.9%
713,616 $44 Million
Q2 2022

Aug 11, 2022
BUY
$57.72 - $65.01 $27,821 - $31,334
482 Added 0.07%
707,239 $43.7 Million
Q1 2022

May 16, 2022
BUY
$57.92 - $72.58 $621,597 - $778,928
10,732 Added 1.54%
706,757 $42 Million
Q4 2021

Feb 14, 2022
BUY
$64.88 - $73.64 $1.77 Million - $2.01 Million
27,354 Added 4.09%
696,025 $50.5 Million
Q3 2021

Nov 15, 2021
BUY
$67.69 - $73.03 $1.28 Million - $1.38 Million
18,941 Added 2.92%
668,671 $46.7 Million
Q2 2021

Aug 13, 2021
BUY
$63.47 - $69.35 $2.18 Million - $2.38 Million
34,314 Added 5.58%
649,730 $44.7 Million
Q1 2021

May 14, 2021
BUY
$60.0 - $68.46 $1.6 Million - $1.82 Million
26,645 Added 4.53%
615,416 $39.8 Million
Q4 2020

Feb 17, 2021
BUY
$56.65 - $64.55 $2.84 Million - $3.23 Million
50,106 Added 9.3%
588,771 $34.3 Million
Q3 2020

Nov 13, 2020
BUY
$62.1 - $78.08 $3.22 Million - $4.05 Million
51,870 Added 10.66%
538,665 $34 Million
Q2 2020

Aug 13, 2020
BUY
$72.34 - $84.0 $2.34 Million - $2.71 Million
32,289 Added 7.1%
486,795 $37.5 Million
Q1 2020

May 15, 2020
SELL
$62.63 - $80.22 $2.07 Million - $2.65 Million
-33,013 Reduced 6.77%
454,506 $33.6 Million
Q4 2019

Feb 14, 2020
BUY
$61.62 - $67.78 $2.77 Million - $3.05 Million
44,993 Added 10.17%
487,519 $31.7 Million
Q3 2019

Nov 14, 2019
BUY
$62.51 - $69.0 $1.47 Million - $1.62 Million
23,544 Added 5.62%
442,526 $28 Million
Q2 2019

Aug 13, 2019
BUY
$61.87 - $69.38 $2.05 Million - $2.29 Million
33,072 Added 8.57%
418,982 $28.3 Million
Q1 2019

May 14, 2019
BUY
$62.53 - $70.05 $9.55 Million - $10.7 Million
152,733 Added 65.5%
385,910 $25.1 Million
Q4 2018

Feb 14, 2019
SELL
$60.54 - $79.0 $781,147 - $1.02 Million
-12,903 Reduced 5.24%
233,177 $14.6 Million
Q3 2018

Nov 14, 2018
SELL
$71.28 - $78.92 $22.4 Million - $24.8 Million
-314,379 Reduced 56.09%
246,080 $19 Million
Q2 2018

Aug 14, 2018
BUY
$64.88 - $75.68 $21.9 Million - $25.6 Million
338,290 Added 152.27%
560,459 $39.7 Million
Q1 2018

May 15, 2018
SELL
$72.84 - $88.8 $10.3 Million - $12.5 Million
-141,083 Reduced 38.84%
222,169 $16.6 Million
Q4 2017

Feb 13, 2018
BUY
$71.15 - $83.52 $2.04 Million - $2.39 Million
28,674 Added 8.57%
363,252 $26.3 Million
Q3 2017

Nov 14, 2017
BUY
$72.11 - $85.47 $1.06 Million - $1.25 Million
14,643 Added 4.58%
334,578 $27.1 Million
Q2 2017

Aug 14, 2017
BUY
N/A
319,935
319,935 $22.6 Million

Others Institutions Holding GILD

# of Institutions
2,083
Shares Held
1.02B
Call Options Held
8.73M
Put Options Held
9.63M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $135B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track United Capital Financial Advisers, LLC Portfolio

Follow United Capital Financial Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on United Capital Financial Advisers, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email